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Available online 6 October 2013Abstract 2,4-Dinitrophenol (DNP) is a neuroprotective compound previously shown to promote neuronal differentiation in a
neuroblastoma cell line and neurite outgrowth in primary neurons. Here, we tested the hypothesis that DNP could induce
neurogenesis in embryonic stem cells (ESCs). Murine ESCs, grown as embryoid bodies (EBs), were exposed to 20 μM DNP (or
vehicle) for 4 days. Significant increases in the proportion of nestin- and β-tubulin III-positive cells were detected after EB
exposure to DNP, accompanied by enhanced glial fibrillary acidic protein (GFAP), phosphorylated extracellular signal-
regulated kinase (p-ERK) and ATP-linked oxygen consumption, thought to mediate DNP-induced neural differentiation. DNP
further protected ESCs from cell death, as indicated by reduced caspase-3 positive cells, and increased proliferation. Cell
migration from EBs was significantly higher in DNP-treated EBs, and migrating cells were positive for nestin, ß-tubulin III and
MAP2, similar to that observed with retinoic acid (RA)-treated EBs. Compared to RA, however, DNP exerted a marked
neuritogenic effect on differentiating ESCs, increasing the average length and number of neurites per cell. Results establish
that DNP induces neural differentiation of ESCs, accompanied by cell proliferation, migration and neuritogenesis, suggesting
that DNP may be a novel tool to induce neurogenesis in embryonic stem cells.
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Neuronal differentiation of embryonic stem cells (ESCs) has
emerged as a potential approach to study and overcome
neurodegenerative disorders, such as Alzheimer's and
Parkinson's diseases (Tomaskovic-Crook and Crook, 2011;
Nikoletopoulou and Tavernarakis, 2012; Visan et al., 2012).
Retinoic acid (RA), a natural morphogen, is extensively used to
induce differentiation of stem cells into a neuronal pheno-
type, but it is also well known to trigger apoptosis and cell
toxicity (Sarkar and Sharma, 2002). On the other hand,
viral-mediated approaches have been employed to deliver
1408 L. Freitas-Correa et al.differentiation factors (Dottori et al., 2011) but they induce
striking transcriptional reprogramming and might not be
safe for human therapy.
2,4-Dinitrophenol (DNP) is classically known as a
mitochondrial uncoupling agent that is toxic at high
concentrations (De Felice and Ferreira, 2006). However,
recent studies have shown that, at low micromolar
concentrations, DNP is neuroprotective. Low-dose DNP
protects against central and peripheral neurodegenera-
tion (Maragos et al., 2003; Pandya et al., 2007; da Costa et
al., 2010), and blocks the aggregation and neurotoxicity of
Alzheimer's amyloid-beta peptide (De Felice et al., 2001;
De Felice, 2004). In addition, DNP has been shown to
promote neuronal differentiation in a neural cell line and
neurite outgrowth in primary cultured neurons, an effect
that is accompanied by stimulation of cAMP signaling
(Wasilewska-Sampaio et al., 2005; Sebollela et al., 2009).
Collectively, these studies suggest that DNP could be a
useful tool in the development of novel therapeutics
against neurodegeneration and brain injury (De Felice et
al., 2007).
Here, we asked whether DNP would induce neural
differentiation in murine ESCs and investigated the mech-
anisms underlying this effect. We found that DNP triggered
neuronal differentiation and cell migration from embryoid
bodies, reduced apoptosis and caused an increase in
neurite density and length in differentiated cells. We
further demonstrate that DNP increases the mitochondrial
ATP turnover coupled to O2 consumption and ERK activa-
tion, mechanisms likely involved in neuronal differentia-
tion. Results indicate that, at low concentrations, DNP
may be a novel, effective and safe drug to integrate
disease modeling and cell-based therapies against neuro-
degenerative diseases.Methods
2,4-dinitrophenol (DNP)
DNP stock solution was freshly prepared immediately before
each experiment at 2 mM. The solution was filtered using a
0.22 μm sterile filter and kept protected from light under
sterile conditions.Cell culture
Murine ESCs (cell line USP1) were kindly provided by Dr. Lygia
Pereira (University of São Paulo-USP) and by Dr. Irina Kerkis
(Federal University of São Paulo). Murine ESCs were grown as
previously described (Marinho et al., 2010; Nones et al., 2010).
Briefly, cell colonies were grown on a mouse embryonic
fibroblast (MEF) feeder layer previously arrested with mito-
mycin C (Sigma), in 15% knockout serum replacement (KSR;
Gibco) — DMEM/F12 (Gibco) supplemented with 1% non-
essential amino acid solution (Gibco), 2 mM L-glutamine
(Gibco), 0.1 mM β-mercaptoethanol (Gibco), 40 mg/mL gen-
tamicin sulfate (Schering-Plough), and 0.2% of conditioned
medium from Chinese hamster ovary (CHO) cells producing
leukemia inhibitory factor (LIF).Formation, treatment and cell migration from
embryoid bodies (EBs)
Murine ESCs (3 × 106 cells) were passed to a 6-well plate
coated with 0.1% gelatin (Sigma) on the first day of culture,
and were cultured for 4 days in 15% KSR-DMEM/F12 media.
At 4 days in vitro, colonies were treated with TrypLE-Express
(Invitrogen) for 5 min at 37 °C, transferred to non-adherent
plate dishes with DMEM/F12 medium with 15% FBS (Gibco)
and cultured for an additional 4 days. Spherical cell aggregates,
denoted embryoid bodies (EBs), assembled between 4 and
8 days in vitro in DMEM/F12 with 15% FBS. Experimental
treatments of EBs were performed from 8 to 12 days in vitro
in LIF-free medium and 15% FBS. Retinoic acid (RA; Sigma) was
used as a positive control to induce neuronal differentiation. At
8 days in vitro, EBs were divided in 3 groups: (a) control,
receiving 0.1% DMSO (RA vehicle) or Milli-Q H2O (DNP vehicle),
(b) treated with 2 μM RA, and (c) treated with 20 μM DNP.
Culture medium was changed every other day. To allow cell
migration, at 12 days in vitro EBs were plated onto 1 mg/mL
laminin- and 1 mg/mL fibronectin-coated dishes and cultured in
DMEM/F12 basal medium with N2 supplement and 20 ng/mL of
fibroblast growth factor-2 for an additional 6 days.
MTT assay
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium) reduction measures the generation of NADH- or
NADPH-dependent chemical potentials within living cells,
providing an assessment of cell viability (Giordano et al.,
2011). MTT reduction was assayed as described (Vieira et al.,
2007). After treatment with DNP or vehicle, EBs were
dissociated with TrypLE-Express (Invitrogen), plated at a
density of 1.0 × 104 cells/well (in 96-well plates) and incubat-
ed for 4 h with 100 μg/mL MTT (Sigma). Cells were disrupted
and formazan blue crystals were dissolved by addition of
100 μL 10% SDS solution in 10 mM HCl. Absorption was
measured at 540 nm in a plate reader after incubation at
25 °C for 16 h.
Immunofluorescence
Prior to immunofluorescence, frozen EB sections (10 μm) or
whole-mountmigrating cells from EBswere permeabilizedwith
0.3% Triton X-100/PBS for 9 min and washed with saline for
5 min. After blocking in 5% bovine serum albumin (Invitrogen)
for 30 min, samples were incubated with the respective pri-
mary antibody overnight. Cells were further incubated in
secondary antibodies (goat anti-mouse IgG conjugated to Alexa
Fluor 546 (Molecular Probes, 1:400)) for 1 h. The samples were
then washed and nuclear counterstaining was performed with
1.0 mg/mL 4,6-diamidino-2-phenylindole (DAPI) for 7 min. EB
sections were imaged on a Nikon Eclipse TE 300 fluorescence
microscope. For cell migration assays, immunofluorescence
was imaged on a Zeiss AxioObserver Z1 microscope equipped
with an Apotome module (Zeiss). For caspase-3 and Ki67
staining, images were acquired on a Nikon confocal microscopy
and are presented as maximal projections.
Primary antibodies anti-nestin (Chemicon; mouse, 1:100),
anti-β-tubulin III (Covance; mouse, 1:100) and anti-MAP2
(Covance; mouse, 1:100) were used to label neural progenitor
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respectively. Primary antibodies anti-caspase 3 (Chemicon;
mouse, 1:100) and anti-Κi67 (Covance; mouse, 1:100) were
used to identify active apoptosis and cell proliferation,
respectively.
The percentages of nestin- or β-tubulin III-positive cells
were determined as follows: for each EB section, photomicro-
graphs taken under 400× microscope magnification were
digitally amplified (150%) using Adobe Photoshop for visualiza-
tion of individual cells within the EB section. A multiplatform
software (Embryonic Stem Cell Counter (ESCC)) was used for
counting DAPI-positive cells from photomicrographs of EB
sections. The software can be freely downloaded (http://
escc.inf.puc-rio.br/) and is further detailed in (Faustino et
al., 2011). An average of 30 EBs (approximately 12,000
DAPI-positive cells) was counted per experimental group
and graphs express means of at least three independent
experiments. Fluorescence integrated density was also
calculated from nestin or β-tubulin III-positive cells. Briefly,
background was removed from fluorescence images and then
converted to 8-bit images. Image analysis platform Columbus
(Perkin Elmer) was used tomeasure the fluorescence intensity
from nestin or β-tubulin III-positive cells in each image.
Results are expressed as the number of cells and fluorescence
intensity ratio. Statistical analysis was performed using one-way
ANOVA followed by Newman–Keuls post-test.
Western blotting
EBs were homogenized in RIPA buffer containing protease and
phosphatase inhibitor cocktails and resolved on 4–20%
polyacrylamide gels with Tris/glycine/SDS buffer run at
125 V for 80 min at room temperature. The gel (30 μg total
protein/lane) was electroblotted onto Hybond ECL nitrocellu-
lose membrane using 25 mM Tris, 192 mM glycine, 20% (v/v)
methanol, 0.02% SDS, pH 8.3, at 350 mA for 2 h at 4 °C.
Membranes were blockedwith 5% non-fatmilk in Tris-buffered
saline containing Tween-20 (TBS-T) (0.1% Tween-20 in 20 mM
Tris–HCl, pH 7.5, 0.9% NaCl) for 1 h at room temperature.
Primary antibodies (anti-GFAP (1:2000; Dako), anti-p-ERK 1/2
(1:500; Cell Signaling) or anti-cyclophilin B (1:10,000; Abcam))
were diluted in 5%milk/TBS and incubatedwith themembranes
overnight at 4 °C. After incubation with HRP-conjugated anti-
mouse or anti-rabbit IgGs (1:10,000 in TBS-T) for 60 min,
membranes were washed, developed with SuperSignal West
Femto Maximum Sensitivity substrate and imaged on photo-
graphic film. Densitometric analyses were performed using
ImageJ (Abràmoff et al., 2004).
Flow cytometry
Cells were harvested as described above, collected in 15 mL
sterile conical tubes and fixed in 4% paraformaldehyde. Cells
were then blocked in PBS with 4% BSA and 0.1% Triton X-100 for
30 min, and placed in conical tubes in aliquots of 500,000 cells
for each replicate. Cells were incubated with anti-cleaved
Caspase 3 (1:400; Cell Signaling) antibody for 1 h at room
temperature, washed 3 times with PBS and incubated with
secondary antibody (Alexa 488-labeled goat anti-rabbit, 1:800).
Flow cytometry was performed on a FACS Calibur cytometer
(Beckman Coulter, Brea, CA) and data analysis was performedusing WinMDI v.2.9. Fluorescence threshold and immuno-
positive cell rates were calculated using WinMDI program.
High-resolution respirometry
Oxygen consumption flux rates were measured polarograph-
ically using high-resolution respirometry as described (Kudin
et al., 1999), with modifications, using an Oroboros Oxygraph
O2K respirometer (Innsbruck, Austria). Measurements were
performed in an electronically controlled thermal environment
with high temperature stability (0.001 °C). The electrode was
calibrated between 0 and 100% (200 μM O2) saturation at
atmospheric pressure (101.3 kPa) at 37 °C. Briefly, EBs were
maintained in Krebs–Ringer solution and 0.5 μM FCCP
(carbonyl cyanide p-tri-fluoromethoxyphenylhydrazone),
1.0 μg/mL oligomycin or 4 mM cyanide (KCN) were sequen-
tially added. The oxygen flux dependence on mitochondrial
ATP-turnover was calculated as the difference between the O2
flux rate in the absence and in the presence of oligomycin, an
inhibitor of FoF1 ATP synthase. Results were normalized by
total protein content and represent means ± SD from three
independent experiments.
Neurite length quantification
Cells were allowed to migrate for 6 days from EBs in culture,
immunolabeled with anti-MAP2, and imaged on a Zeiss Axioplan
(Apotome mode) microscope for morphometric analyses. The
density of neurites per cell and the length of individual neurites
were analyzed using Sigma Scan Pro Software (Jandel Scientific,
San Rafael, CA, USA). Three independent experiments were
performed and at least 100 cells were analyzed in each
experiment.
Results
2,4-dinitrophenol promotes neural differentiation
in EBs
To determine whether DNP had an effect on murine ESC
neural differentiation, we exposed EBs to vehicle or 20 μM
DNP for 4 days and then evaluated the percentage of cells
positive for nestin or β-tubulin III. Compared to control
EBs, DNP markedly increased the proportion of both
nestin- (Figs. 1A–F) and β-tubulin III-positive (Figs. 1G–L)
cells, as well as the levels of these proteins (Figs. 1E, K),
suggesting an increase in both proliferative neuronal
progenitors (nestin-positive cells) and cells committed to
a neuronal phenotype (β-tubulin III-positive cells). Fur-
thermore, DNP-treated EBs exhibited increased glial
fibrillary acidic protein (GFAP) level (Fig. 1N), consistent
with generation of astroglial cells.
Extracellular signal-regulated kinase 1/2 (ERK 1/2) is an
important cellular effector that responds to hormone and
morphogen signaling (Burdon et al., 2002; Yao, 2003).
Importantly, ERK 1/2 activation has been implicated in
neuronal differentiation of ESCs (Li et al., 2006) and progenitor
proliferation in the brain (Nuttall and Oteiza, 2011; Pucilowska
et al., 2012). We thus investigated whether DNP-induced
neural differentiation involved ERK activation and found that
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1411Neurogenic actions of DNP in embryonic stem cellsDNP triggers ERK 1/2 phosphorylation at Thr202/Tyr204,
residues that correspond to activation sites for this enzyme
(Fig. 1M). Results thus demonstrate that DNP induces neural
commitment of murine ESCs, a process likely mediated by ERK
signaling. However, combination of DNP and RA did not result
in synergic effect or enhanced differentiation (Suppl. Fig. 3).
2,4-dinitrophenol decreases cell death and boosts
cell proliferation in EBs
Cell viability analyses showed that treatment with 20 μM DNP
did not affect the morphological integrity of EBs (Suppl. Fig.
1A, B) or MTT reduction (Suppl. Fig. 1D). In contrast, a higher
dose of DNP (500 μM) was clearly cytotoxic, as evidenced by
cell detachment from EBs and reduced MTT reduction (Suppl.
Fig. 1C, D). The lack of effect of low-dose DNP on MTT
reduction suggests a preserved cell viability, evidenced by
intact NADPH-dependent reductase activity, in contrast to the
toxicity of 500 μM DNP.
During EB assembly, cavitation naturally occurs through
programmed cell death (Hernández-García et al., 2008).
Moreover, RA-mediated cell differentiation increases the
rate of apoptotic cell death, thereby reducing EB viability
(Okazawa et al., 1996; Sarkar and Sharma, 2002; Pfahl and
Piedrafita, 2003). Thus, we set out to investigate whether DNP
would affect caspase-3 activation in EBs undergoing differen-
tiation. Interestingly, DNP (20 μM) significantly reduced the
percentage of active caspase 3-positive cells compared to
vehicle-treated EBs, whereas RA treatment induced a signif-
icant increase in caspase 3-positive cells (Figs. 1O–S). These
data indicate that, in sharp contrast with RA, DNP protects
ESCs against caspase-3 activation and allows higher cell
viabilities.
In the course of these experiments, we noted that EBs
exposed to DNP for 4 days were frequently larger than those
treated with vehicle or RA (Suppl. Fig. 2A, B). This observation
led us to investigate whether, in addition to increased cell
survival, cell proliferation in the EBs was stimulated by DNP
treatment. Indeed, we found that DNP treatment led to
increased absolute cell number (Suppl. Fig. 2C) and Ki67
immunostaining (Suppl. Fig. 2D-G), indicating increased cell
proliferation in the EBs.
2,4-dinitrophenol alters O2 consumption in EBs
Changes in cellular oxygen consumption and oxidative status
have been linked to cellular differentiation, either to the neural
or to other phenotypes (Vieira et al., 2011). We thereforeFigure 1 DNP promotes neural commitment in murine embryoid bo
D) staining in control and DNP-treated EBs at 12 days in vitro, follow
fluorescence integrated density (E) and percentage of nestin-po
Immunohistochemistry (H, J) staining in control and DNP-treated
fluorescence integrated density (K) and percentage of β-tubulin III-p
was applied to eliminate background staining. (M, N) DNP significant
marker GFAP (N) in EBs. (O) FACS histogram of control (red line), RA
indicated as a green dashed line. (P) FACS analysis for active caspas
were analyzed per condition per experiment. (Q–S) Immunohist
DNP-treated (R) or RA-treated (S) EBs. Scale bar: 25 μm. * p-values b
assessed at 12 DIV.sought to evaluate the profile of oxygen consumption after
treatment of EBs with 20 μM DNP using high-resolution
respirometry. Compared to control EBs, we found that
DNP-treated EBs showed a significant increase in the rate of
mitochondria-associated O2 consumption, as the portion of O2
consumption inhibited by antimycin A, a specific inhibitor of
complex III of electron transport system, was more than 2-fold
higher than that observed in untreated EBs (Fig. 2A). To
determine the rate of mitochondrial ATP synthesis-dependent
O2 consumption, we inhibited ATP synthase with oligomycin.
Under these conditions, we found that DNP-treated EBs
displayed increased ATP synthesis-coupled respiration com-
pared to control (Fig. 2B). Similar results were obtained after
addition of FCCP, which disrupts the mitochondrial membrane
potential, and potassium cyanide, which completely inhibits
mitochondrial respiration, allowing determination of mitochon-
drial and non-mitochondrial O2 consumption (Fig. 2A). These
results establish that DNP elevates the rate of cellular O2
consumption that is coupled to ATP production within the EBs
and suggest that changes in aerobic metabolic profile might
underlie neuronal differentiation induced by DNP.
2,4-Dinitrophenol promotes cell migration from
murine EBs
Cell migration from EBs generally accompanies differentia-
tion under appropriate in vitro conditions and has been
extensively utilized as a tool to investigate mechanisms of
neuronal specification of ESCs (Bibel et al., 2007). DNP
significantly increased numbers of migrating cells compared
to control EBs (Figs. 3A, C, D), similar to the effect induced
by RA treatment (Figs. 3B–D). DNP further increased
migrating cell area (Figs. 3E–H) to an extent comparable to
RA. Results demonstrate that DNP is as efficient as RA in
inducing cell migration from EBs.
2,4-dinitrophenol stimulates neuronal differentiation
in migrating murine ESCs
During brain development, neuroblast migration along es-
tablished paths is accompanied by maturation and pheno-
type expression (Platel et al., 2008). We thus examined
whether cells migrating from EBs were indeed entering a
differentiation program when exposed to DNP. We found
that such cells exhibited marked increases in both nestin
(Figs. 3I–L) and β-tubulin III (Figs. 3M–P) immunolabeling
compared to control cells. When compared to RA, DNP
treatment induced similar percentages of nestin-positivedies (EBs). (A–D) DAPI (A, C) or nestin immunohistochemistry (B,
ing 4 days of treatment with DNP. (E–F) Quantification of nestin
sitive cells (F) within EBs. (G–J) DAPI (G, I) or β-tubulin III
EBs. Scale bar: 50 μm. (K–L) Quantification of β-tubulin III
ositive cells (L) within EBs. Adequate fluorescence thresholding
ly increases ERK 1/2 phosphorylation (M) and levels of astroglial
- (gray) or DNP-treated (black) cells. Threshold fluorescence is
e-3 in control EBs, or EBs treated with DNP or RA. 5 × 104 cells
ochemistry analysis showing active caspase-3 in control (Q),
0.05; all experiments were based on three independent samples
Figure 2 DNP alters O2 flux in murine embryonic stem cells (ESCs). (A) Representative histogram of O2 flux in control (pink) or
DNP-treated (black line) EBs. (B) Oligomycin-sensitive O2 flux in control (white) or DNP-treated (black bar) EBs. * p-values b 0.05.
Bars display means ± SD of 3 independent assays at 8 DIV.
1412 L. Freitas-Correa et al.progenitors (Figs. 3I–L) but was clearly more efficient in
generating β-tubulin III-positive cells (Figs. 3M–P).
2,4-dinitrophenol generates mature neurons and
promotes neuritogenesis in newly differentiated
neurons
We next sought to determine whether DNP had the capacity to
induce phenotypical maturation of murine ESC-derived neu-
rons. To this end, we assessed MAP2 immunoreactivity as a
marker of mature neurons and found that both RA and DNP
increased MAP2-positive cells to similar extents (Figs. 4A–D).
Interestingly, however, DNP-treated mESC cultures exhibited
neurons with prominent neurites, leading us to hypothesize
that DNP might have an important neuritogenic activity on
differentiated neurons. Results showed that, while RA treat-
ment stimulated generation of shorter neurites (b100 μm in
length), DNP-treated cells displayed a significantly higher
frequency of longer neurites (N200 μm) (Figs. 4A–E). Further-
more, in contrast to RA treatment, DNP prompted an increase
in the frequency of neurons exhibiting three or more neurites
(Fig. 4F).
Discussion
Development of protocols for neuronal differentiation of
embryonic stem cells (ESCs) has been a focus of intense
research due to their potential to integrate therapeutic
approaches to prevent or treat neurodegeneration (Bull and
Martin, 2011; López-González and Velasco, 2012). Although
a number of molecules and strategies have been proposed to
achieve neural differentiation, further optimization of existing
protocols is still required to circumvent toxicity and facilitate
cell survival and function.
In vitro differentiation of ESCs into neuronsmost frequently
employs the natural morphogen retinoic acid (RA), either
alone or in combination with other compounds (Dhara and
Stice, 2008). However, RA treatment of progenitor cells has
the disadvantage of triggering apoptotic cell death and a
reduction in cell viability (Sarkar and Sharma, 2002; Huang etal., 2013), prompting the development of novel neurogenic
approaches (Wang et al., 2009; Paulsen et al., 2011;Wu et al.,
2013). In fact, recently developed protocols attempt to
enhance the efficiency of neuronal differentiation by dually
targeting Wnt and BMP signaling (Osakada and Takahashi,
2011).
2,4-Dinitrophenol (DNP) is well known to be cytotoxic at
high concentrations. However, recent studies have demon-
strated that at low micromolar, non-toxic concentrations,
DNP has neuroprotective properties in a number of in vitro
and in vivo models of neurodegeneration (reviewed in (De
Felice and Ferreira, 2006)). Further, we have previously
reported that DNP promotes neuritogenesis in neuronal
primary cultures and induces neuronal differentiation of a
neuroblastoma cell line (Wasilewska-Sampaio et al., 2005).
We here demonstrate that DNP-treated murine embryonic
stem cells acquire a neuron-like phenotype, with increased
immunoreactivity for neuronal markers, migration from
embryoid bodies (EBs) and marked neuritogenesis. Sig-
nificantly, cell differentiation induced by DNP was, by a
number of criteria, comparable to differentiation induced by
RA, with the advantage of stimulating cell survival and neurite
extension. In particular, DNP decreased caspase-3-positive
cells and increased cell proliferation in EBs, and markedly
stimulated neuritogenesis and arborization of differentiat-
ed cells. Curiously, we did not observe a synergistic effect
of DNP and RA combined in promoting neuronal differenti-
ation from ESCs. This advocates for different and poten-
tially opposing mechanisms underlying each compound
action. Taken together, however, our results suggest that
DNP is as effective as RA in promoting neuronal differen-
tiation of ESCs.
In an attempt to understand the early molecular changes
underlying DNP-induced neurogenesis, we found that nestin
and β-tubulin III levels were increased in DNP-treated EBs,
suggesting that DNP triggers an initial commitment to a
neuronal phenotype within the EBs. In addition, increased
levels of glial fibrillary acidic protein (GFAP) suggest that
astrocytes are also initially generated upon DNP treatment
and may further contribute to in vitro neuronal development
and survival, as previously suggested (Akanuma et al., 2012).
Figure 3 DNP increases cell migration, induces differentiation and neuronal fate in murine ESCs. (A–C) Representative images of
migration area in control (A), RA- (B) or DNP-treated embryoid bodies (EBs) (C). (D) Quantification of migration area after RA or DNP
treatment. Migration area is defined as the difference between total DAPI-positive area (yellow line) minus observed EB area (white
line). Images are reconstructions from six independent fields imaged for each EB. Representative images of cell migration in control
(E), RA- (F) and DNP-treated EBs (G). (H) Quantification of migrating cells per EB after RA or DNP treatment. Immunofluorescence
analysis showing nestin-positive staining in control (I), RA-treated EBs (J) or DNP-treated EBs (K). (L) Quantification of migrating
nestin-positive cells. Immunofluorescence analysis in control (M), RA-treated EBs (N) or DNP-treated EBs (O) showed migrating cells
positive for β-tubulin III staining. (P) Quantification of migrating β-tub III-positive cells. *p-values b 0.05; **p-values b 0.001;
#p-values b 0.0001; all experiments were based on at least three independent samples; scale bar: 100 μm.
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genesis and neuroprotection have not been fully elucidated, our
finding that DNP increases ERK 1/2 phosphorylation suggests
that ERK activationmay be involved, as previously described for
neuronal differentiation of stem cells (Li et al., 2006; Moon et
al., 2009) and normal brain development (Nuttall and Oteiza,
2011; Pucilowska et al., 2012). Previous studies from our group
further support the notion that the neuroprotective actions
of DNP involve stimulation of cyclic AMP (cAMP) signaling
(Wasilewska-Sampaio et al., 2005; Sebollela et al., 2009). A
crosstalk between PKA/cAMP andMEK/ERK appears to facilitate
neural differentiation and neuritogenesis (De Felice et al.,
2007) and thusmight contribute to DNP-induced neurogenesis inESCs. Indeed, ERK activation was found to be required for
DNP-induced neuronal differentiation of a neuroblastoma cell
line (Wasilewska-Sampaio et al., 2005).
We also report a protective action of DNP during neural
differentiation of ESCs. As expected (Huang et al., 2013),
RA-mediated differentiation involved an increase in the
percentage of active caspase-3 cells within the EBs. On the
other hand, DNP promoted neurogenesis while lowering
caspase-3 activation, suggesting a cytoprotective role that
might be relevant for cell survival and phenotype stability
during and after neural differentation.
DNP is classically described as a mitochondrial uncoupling
agent and we thus hypothesized that this property might
Figure 4 DNP induces neuritogenesis in newly differentiated neurons. Immunofluorescence analysis in control (A), RA-treated EBs (B) or
DNP-treated EBs (C) for MAP2-positive migrating cells. (D) Quantification of MAP2-positive migrating cells. (E) Frequency distribution of
primary neurite lengths in MAP2-positive cells after migration from control, RA-treated or DNP-treated EBs. (F) Average number of primary
neurites per MAP2-positive cell migrating from control, RA-treated or DNP-treated EBs. *p-values b 0.001; all experiments were based on
three independent samples; scale bar: 100 μm.
1414 L. Freitas-Correa et al.underlie cytoprotection and neurogenesis in ESCs. Interestingly,
however, we found that DNP increases ATP synthesis-linked O2
consumption. This supports the idea that DNP does not cause
mitochondrial uncoupling at this concentration, despite
evident neural differentiation status. Indeed, alterations in
oxygen availability and mitochondrial bioenergetics have
been linked to molecular signaling pathways that trigger
differentiation across development (Birket et al., 2011; Mutoh
et al., 2012). In this regard, future studies may help elucidate
the mechanisms by which mitochondrial modulation is linked
to the pro-neurogenic action of DNP.
Finally, we present evidence that DNP induces a neuronal
fate in ESCs, as indicated by expression of neuronal markers
β-tubulin III and MAP2. This was accompanied by pronounced
arborization and neurite elongation, in a significantly higher
magnitude than in RA-treated cells. In conclusion, the current
results indicate that DNP promotes cell survival and neuronal
differentiation in pluripotent stem cells. Future studies are
needed to compare the DNP-based protocol we here describe
to other recently developed neuronal differentiation methods.
Nevertheless, we suggest that DNP may be used, as an
advantageous alternative to RA, to generate consistentneuronal phenotypes from ESCs, serving as a novel tool for
investigation of mechanisms of neurogenesis and, possi-
bly, for development of models of neurodegenerative and
neuropsychiatric disorders.
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